首页 › 溃疡性结肠炎 › 得克萨斯州 › San Antonio
San Antonio TX 溃疡性结肠炎临床试验
16项针对 溃疡性结肠炎的研究正在 San Antonio及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Southern Star Research Institute /ID# 280822, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
招募中2 期
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
招募中2 期
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
招募中4 期
- Gastroenterology Research of San Antonio, LLC, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
招募中1/2 期欢迎健康志愿者
- Xencor Investigative Site, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
招募中3 期
- Southern Star Research Institute ( Site 0299), San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
招募中2 期
- Southern Star Research Institute, San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Southern Star Research Institute, LLC, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
招募中2 期
- Site 002, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Gastroenterology Research of San Antonio, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
招募中观察性研究
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
其他城市的 溃疡性结肠炎试验
- New York City, NY24 项研究
- Miami, FL22 项研究
- Orlando, FL22 项研究
- Houston, TX17 项研究
- San Diego, CA15 项研究
- Chicago, IL15 项研究
- Tacoma, WA14 项研究
- Colorado Springs, CO14 项研究
- Tyler, TX13 项研究
- Los Angeles, CA13 项研究
- St. Louis, MO13 项研究
- Washington, DC12 项研究
San Antonio的其他研究
- 非小细胞肺癌59 项研究
- 乳腺癌46 项研究
- 结直肠癌46 项研究
- 转移性癌症44 项研究
- 癌症（所有类型）41 项研究
- 肥胖症40 项研究
- 2型糖尿病36 项研究
- 超重34 项研究
- 胰腺癌31 项研究
- 卵巢癌31 项研究
- 前列腺癌28 项研究
- 子宫内膜癌27 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月29日。每项研究自行设定入选标准，由研究团队决定谁能参与。